期刊
JOURNAL OF ONCOLOGY
卷 2009, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2009/519563
关键词
-
类别
资金
- NIH [RO1-CA100045, KO1-CA134941, T32-CA078586-08, R01CA133114, P30-CA086862]
- Department of Radiation Oncology at the University of Iowa
- NATIONAL CANCER INSTITUTE [T32CA078586, R01CA133114, K01CA134941, R01CA100045, P30CA086862] Funding Source: NIH RePORTER
The hypothesis that the Akt inhibitor, perifosine (PER), combined with inhibitors of glutathione (GSH) and thioredoxin (Trx) metabolism will induce cytotoxicity via metabolic oxidative stress in human head and neck cancer (HNSCC) cells was tested. PER induced increases in glutathione disulfide (% GSSG) in FaDu, Cal-27, and SCC-25 HNSCCs as well as causing significant clonogenic cell killing in FaDu and Cal-27, which was suppressed by simultaneous treatment with N-acetylcysteine (NAC). An inhibitor of GSH synthesis, buthionine sulfoximine (BSO), sensitized Cal-27 and SCC-25 cells to PER-induced clonogenic killing as well as decreased total GSH and increased % GSSG. Additionally, inhibition of thioredoxin reductase activity (TrxRed) with auranofin (AUR) was able to induce PER sensitization in SCC-25 cells that were initially refractory to PER. These results support the conclusion that PER induces oxidative stress and clonogenic killing in HNSCC cells that is enhanced with inhibitors of GSH and Trx metabolism. Copyright (C) 2009 Andrean L. Simons et al.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据